Marta Seco-Cervera1,2,3†
José Santiago Ibáñez-Cabellos4†
Federico V. Pallardo1,2,3
José-Luis García-Giménez1,2,3
Anna Aulinas5,6,7*
Luciana Martel-Duguech5
Susan M. Webb5,6,8*Elena Valassi6,9,10*- 1Unit 733, Centre for Biomedical Network Research on Rare Diseases [CIBERER- Instituto de Salud Carlos III (ISCIII)], Madrid, Spain
- 2Mixed Unit for rare diseases INCLIVA-CIPF, INCLIVA Health Research Institute, Valencia, Spain
- 3Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia, Valencia, Spain
- 4EpiDisease S.L., Scientific Park, University of Valencia, Paterna, Spain
- 5Department of Endocrinology, Hospital S Pau, Research Center for Pituitary Diseases, Institut de Recerca Sant Pau (IIB-Sant Pau), Barcelona, Spain
- 6CIBERER Unit 747, Instituto de Salud Carlos III, Madrid, Spain
- 7Department of Medicine, Universitat de Vic-Universitat Central de Catalunya, Vic, Spain
- 8Department of Medicine, Univ Autonoma Barcelona, Bellaterra, Spain
- 9Endocrinology and Nutrition Department, Germans Trias i Pujol Hospital and Research Institute, Badalona, Spain
- 10School of Medicine, Universitat Internacional de Catalunya (UIC), Sant Cugat del Vallès, Barcelona, Spain
A Corrigendum on
Circulating miR-28-5p is overexpressed in patients with sarcopenia despite long-term remission of Cushing’s syndrome: a pilot study
by Seco-Cervera M, Ibáñez-Cabellos JS, Pallardo FV, García-Giménez J-L, Aulinas A, Martel-Duguech L, Webb SM and Valassi E (2024). Front. Endocrinol. 15:1410080. doi: 10.3389/fendo.2024.1410080
In the published article, there was an error in the Funding statement. The funding statement was displayed as “The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.”. The correct Funding statement appears below.
“The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by a grant from the Instituto de Salud Carlos III (FIS PI21/01223; PI, Elena Valassi), European Regional Development Fund (FEDER) funds.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: microRNA, miR-28-5p, myomiRs, sarcopenia, myopathy, Cushing syndrome
Citation: Seco-Cervera M, Ibáñez-Cabellos JS, Pallardo FV, García-Giménez J-L, Aulinas A, Martel-Duguech L, Webb SM and Valassi E (2025) Corrigendum: Circulating miR-28-5p is overexpressed in patients with sarcopenia despite long-term remission of Cushing’s syndrome: a pilot study. Front. Endocrinol. 16:1587462. doi: 10.3389/fendo.2025.1587462
Received: 04 March 2025; Accepted: 30 May 2025;
Published: 19 June 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Seco-Cervera, Ibáñez-Cabellos, Pallardo, García-Giménez, Aulinas, Martel-Duguech, Webb and Valassi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Anna Aulinas, YWF1bGluYXNAc2FudHBhdS5jYXQ=; Susan M. Webb, d2ViYnN1c2FuNEBnbWFpbC5jb20=; Elena Valassi, ZXZhbGFzc2lAaWd0cC5jYXQ=
†These authors share first authorship